Skip to main content
SpringerLink
Log in

Kostengünstiges für Schwellenländer

Niedrigdosiertes Theophyllin zum Prednisolon hat bei COPD keinen Vorteil

  • Journalclub
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Horita N, Miyazawa N, Kojima M et al. Chronic Use fo Theophylline and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-Analysis. Arch Bronconeumol. 2016;52(5):233-8

  2. Cosio BG, Tsaprouni L, Ito K et al. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med. 2004;200(5):689-95

  3. Global Initiative für Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (2021 Report). www.goldcopd.org

  4. Kunisaki KM, Sin DD. Methylxanthines in COPD: yes to caffeine, no to theophylline. Eur Respir J. 2021;57(6):2004564

Download references

Author information

Authors and Affiliations

  1. Pneumologische Praxis, Rolshover Str. 526, 51105, Köln, Germany

    Justus de Zeeuw

Authors
  1. Justus de Zeeuw
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Justus de Zeeuw.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Zeeuw, J. Niedrigdosiertes Theophyllin zum Prednisolon hat bei COPD keinen Vorteil. Pneumo News 13, 24–25 (2021). https://doi.org/10.1007/s15033-021-2741-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-021-2741-9

Search

Navigation